Report Detail
COVID-19 Impact on Global Viral Vector Manufacturing Services Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4088260 |
- 06 July, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Other
Market Analysis and Insights: Global Viral Vector Manufacturing Services Market
The research report studies the Viral Vector Manufacturing Services market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Viral Vector Manufacturing Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Viral Vector Manufacturing Services Scope and Segment
The global Viral Vector Manufacturing Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector Manufacturing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Retroviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Other Viral Vectors
by Application, this report covers the following segments
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
Global Viral Vector Manufacturing Services market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Viral Vector Manufacturing Services key players in this market include:
Novasep
Lonza Pharma & Biotech
ABL, Inc.
Takara Bio
Sartorius
Cobra Biologics
Finvector
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
uniQure
1 Market Overview of Viral Vector Manufacturing Services
- 1.1 Viral Vector Manufacturing Services Market Overview
- 1.1.1 Viral Vector Manufacturing Services Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global Viral Vector Manufacturing Services Market Size Overview by Region 2015 VS 2020 VS 2026
- 1.3 Global Viral Vector Manufacturing Services Market Size by Region (2015-2026)
- 1.4 Global Viral Vector Manufacturing Services Historic Market Size by Region (2015-2020)
- 1.5 Global Viral Vector Manufacturing Services Market Size Forecast by Region (2021-2026)
- 1.6 Key Regions, Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
- 1.6.1 North America Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
- 1.6.2 Europe Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
- 1.6.3 Asia-Pacific Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
- 1.6.4 Latin America Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
- 1.6.5 Middle East & Africa Viral Vector Manufacturing Services Market Size YoY Growth (2015-2026)
2 Viral Vector Manufacturing Services Market Overview by Type
- 2.1 Global Viral Vector Manufacturing Services Market Size by Type: 2015 VS 2020 VS 2026
- 2.2 Global Viral Vector Manufacturing Services Historic Market Size by Type (2015-2020)
- 2.3 Global Viral Vector Manufacturing Services Forecasted Market Size by Type (2021-2026)
- 2.4 Retroviral Vectors
- 2.5 Adenoviral Vectors
- 2.6 Adeno-associated Viral Vectors
- 2.7 Other Viral Vectors
3 Viral Vector Manufacturing Services Market Overview by Application
- 3.1 Global Viral Vector Manufacturing Services Market Size by Application: 2015 VS 2020 VS 2026
- 3.2 Global Viral Vector Manufacturing Services Historic Market Size by Application (2015-2020)
- 3.3 Global Viral Vector Manufacturing Services Forecasted Market Size by Application (2021-2026)
- 3.4 Pharmaceutical and Biopharmaceutical Companies
- 3.5 Research Institutes
4 Global Viral Vector Manufacturing Services Competition Analysis by Players
- 4.1 Global Viral Vector Manufacturing Services Market Size (Million US$) by Players (2015-2020)
- 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing Services as of 2019)
- 4.3 Date of Key Manufacturers Enter into Viral Vector Manufacturing Services Market
- 4.4 Global Top Players Viral Vector Manufacturing Services Headquarters and Area Served
- 4.5 Key Players Viral Vector Manufacturing Services Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Viral Vector Manufacturing Services Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Novasep
- 5.1.1 Novasep Profile
- 5.1.2 Novasep Main Business
- 5.1.3 Novasep Products, Services and Solutions
- 5.1.4 Novasep Revenue (US$ Million) & (2015-2020)
- 5.1.5 Novasep Recent Developments
- 5.2 Lonza Pharma & Biotech
- 5.2.1 Lonza Pharma & Biotech Profile
- 5.2.2 Lonza Pharma & Biotech Main Business and Company’s Total Revenue
- 5.2.3 Lonza Pharma & Biotech Products, Services and Solutions
- 5.2.4 Lonza Pharma & Biotech Revenue (US$ Million) (2015-2020)
- 5.2.5 Lonza Pharma & Biotech Recent Development and Reaction to Covid-19
- 5.3 ABL, Inc.
- 5.5.1 ABL, Inc. Profile
- 5.3.2 ABL, Inc. Main Business
- 5.3.3 ABL, Inc. Products, Services and Solutions
- 5.3.4 ABL, Inc. Revenue (US$ Million) & (2015-2020)
- 5.3.5 Takara Bio Recent Developments
- 5.4 Takara Bio
- 5.4.1 Takara Bio Profile
- 5.4.2 Takara Bio Main Business
- 5.4.3 Takara Bio Products, Services and Solutions
- 5.4.4 Takara Bio Revenue (US$ Million) & (2015-2020)
- 5.4.5 Takara Bio Recent Developments
- 5.5 Sartorius
- 5.5.1 Sartorius Profile
- 5.5.2 Sartorius Main Business
- 5.5.3 Sartorius Products, Services and Solutions
- 5.5.4 Sartorius Revenue (US$ Million) & (2015-2020)
- 5.5.5 Sartorius Recent Developments
- 5.6 Cobra Biologics
- 5.6.1 Cobra Biologics Profile
- 5.6.2 Cobra Biologics Main Business
- 5.6.3 Cobra Biologics Products, Services and Solutions
- 5.6.4 Cobra Biologics Revenue (US$ Million) & (2015-2020)
- 5.6.5 Cobra Biologics Recent Developments
- 5.7 Finvector
- 5.7.1 Finvector Profile
- 5.7.2 Finvector Main Business and Company’s Total Revenue
- 5.7.3 Finvector Products, Services and Solutions
- 5.7.4 Finvector Revenue (US$ Million) (2015-2020)
- 5.7.5 Finvector Recent Development and Reaction to Covid-19
- 5.8 Fujifilm Diosynth Biotechnologies
- 5.8.1 Fujifilm Diosynth Biotechnologies Profile
- 5.8.2 Fujifilm Diosynth Biotechnologies Main Business
- 5.8.3 Fujifilm Diosynth Biotechnologies Products, Services and Solutions
- 5.8.4 Fujifilm Diosynth Biotechnologies Revenue (US$ Million) & (2015-2020)
- 5.8.5 Fujifilm Diosynth Biotechnologies Recent Developments
- 5.9 Sanofi
- 5.9.1 Sanofi Profile
- 5.9.2 Sanofi Main Business
- 5.9.3 Sanofi Products, Services and Solutions
- 5.9.4 Sanofi Revenue (US$ Million) & (2015-2020)
- 5.9.5 Sanofi Recent Developments
- 5.10 Spark Therapeutics
- 5.10.1 Spark Therapeutics Profile
- 5.10.2 Spark Therapeutics Main Business
- 5.10.3 Spark Therapeutics Products, Services and Solutions
- 5.10.4 Spark Therapeutics Revenue (US$ Million) & (2015-2020)
- 5.10.5 Spark Therapeutics Recent Developments
- 5.11 uniQure
- 5.11.1 uniQure Profile
- 5.11.2 uniQure Main Business
- 5.11.3 uniQure Products, Services and Solutions
- 5.11.4 uniQure Revenue (US$ Million) & (2015-2020)
- 5.11.5 uniQure Recent Developments
6 North America
- 6.1 North America Viral Vector Manufacturing Services Market Size by Country
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Viral Vector Manufacturing Services Market Size by Country
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Viral Vector Manufacturing Services Market Size by Country
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Viral Vector Manufacturing Services Market Dynamics
- 11.1 Industry Trends
- 11.2 Market Drivers
- 11.3 Market Challenges
- 11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Viral Vector Manufacturing Services. Industry analysis & Market Report on COVID-19 Impact on Global Viral Vector Manufacturing Services is a syndicated market report, published as COVID-19 Impact on Global Viral Vector Manufacturing Services Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Viral Vector Manufacturing Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
